LHRH-agonists in Early Breast Cancer Overview group (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive ...

As over half of all early-stage breast cancers remain estrogen-receptor-positive, the goal of adjuvant hormone therapy is to reduce the local concentrations of estrogen. Sharma and colleagues ...